Latest on CVS-Caremark Merger

CVS made what it calls its "best and final" offer for Caremark, raising the cash dividend from $6 to $7.50, for a deal valued at $26 billion.  The Caremark shareholders are scheduled to vote on the merger on March 16.  ExpressScripts' rival bid is still higher at $26.3 billion, but it faces regulatory delays with the FTC.  SeeNYTimes, CVS Again Increases Its Offer for Caremark and WSJ, CVS Makes 'Final' Bid to Secure Caremark.